TAVR for bicuspid aortic valve with a specific device
Part of Heart & circulation clinical trials.
This study tests a “solution” approach using a self-expanding valve during TAVR (a less invasive way to replace a narrowed aortic valve). It aims to improve how well the valve fits and works in people with a specific heart valve shape (bicuspid aortic stenosis).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are getting TAVR through the thigh blood vessels (transfemoral approach).
- You have severe bicuspid aortic valve narrowing (aortic stenosis) with test-confirmed measurements.
- You are at least 65, or 60–64 with high surgical risk based on risk and health-function assessments.
- Your heartbeat symptoms are at least moderate (NYHA class II or higher).
- CT scan shows the valve shape is Sievers type 0 or type 1, and the valve opening size fits the study range.
- You must not have major problems that make valve placement unsafe (example: certain vessel/tortuous anatomy or high risk for complications by CT review).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This trial compares a “smaller valve sizing” approach versus the usual sizing method during TAVR (a catheter-based valve replacement) for people with bicuspid aortic stenosis. The study aims to see which method improves safety and outcomes for the right valve fit.
This study tests a special sizing method (ABC algorithm) to help doctors select the right valve for people with a bicuspid aortic valve. It aims to improve outcomes for those getting a Sapien 3 valve through a catheter (TAVR).
This study looks at how safe and effective the SAPIEN 3 valve is for patients in China who have a specific type of bicuspid aortic valve (Type-0) that is severely narrowed. If you have severe aortic stenosis and meet the criteria, this treatment might be an option for you.
This trial tests two types of replacement heart valves (self-expanding and balloon-expanding) in people who have severe aortic stenosis (tight heart valve) and an enlarged aorta (the main blood vessel from the heart). The goal is to see which valve type works better for these patients.
This trial tests a minimally invasive procedure called TAVI (transcatheter aortic valve implantation) to replace a narrowed aortic valve without requiring open-heart surgery. The study is checking whether TAVI can be safely performed at hospitals that don't have cardiac surgery units on-site.
Hear when a new Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.